Professor Vlado Perkovic

Vlado Perkovic is currently Executive Director of The George Institute, Australia, Scientia Professor with the Faculty of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. He will be moving into the role of Dean of Medicine, UNSW in October 2019. Vlado’s research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several international clinical trials, and has been involved in developing Australian and global treatment guidelines. He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017.

Vlado is the President of the Association of Australian Medical Research Institute and a member of the National Health and Medical Research Council Principal Committee on Research Translation, and is on the Board of the Australian Clinical Trials Alliance. He is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, and the Australian Academy of Health and Medical Sciences. He serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine.

Professor Peter Macdonald AM MBBS FRACP PHD MD

Peter Macdonald is a Conjoint Professor of Medicine in the University of New South Wales, Medical Director of the Heart Transplant Unit at St Vincent's Hospital, Sydney and head of the Transplantation Research Laboratory at the Victor Chang Cardiac Research Institute. He is a past President of the Transplantation Society of Australia & New Zealand (TSANZ). His major research interests over the last 30 years have been in the areas of heart failure, heart transplantation, donor management and organ preservation. He has co-authored over 300 peer-reviewed manuscripts, more than 30 invited manuscripts and has contributed to the development of 10 national guidelines on these subjects. His current H index is 57. In 2010, 2015, 2017 and 2019 he was nominated for the Award of Australian of the Year. In 2015 his research into the recovery and transplantation of hearts from DCD donors was recognised by the NSW Government with the NSW Ministerial Award for cardiovascular research excellence and by the ACT Gift of Life Organisation with the Terry Connolly Award for Healthcare Leadership and Innovation. In 2017, he was made a member of the Order of Australia.

Professor David McGiffin

Professor McGiffin graduated from the University of Queensland Medical School and subsequently interned and trained in General Surgery at Princess Alexandra Hospital, Brisbane before going on to train in Cardiothoracic Surgery at the Prince Charles Hospital. In 1982, Professor McGiffin went to the United States as a Fulbright Scholar and undertook a Fellowship at the University of Alabama at Birmingham (UAB). He joined the faculty at UAB but returned to Australia in 1986 to The Prince Charles Hospital where he did adult and paediatric cardiac surgery and also set up the Queensland Heart Transplant Program. In 1992, Professor McGiffin returned to UAB where his clinic duties included the full range of adult cardiac surgery and heart and lung transplantation. He commenced a pulmonary endarterectomy program for chronic thromboembolic pulmonary hypertension.

Professor McGiffin returned to Australia in 2013 to take up a position as Director of Cardiothoracic Surgery at the Alfred Hospital. His clinical practice includes adult cardiac surgery, heart and lung transplantation, ventricular assist devices and pulmonary endarterectomy. His major research work involves investigating mechanisms of driveline infection after implantation of ventricular assist devices and hypothermic perfusion to extend the ischemic time of donor hearts for transplantation.